The FDA has cleared an Investigational New Drug (IND) application for SB-007, an adeno-associated vi...
read moreTenpoint Therapeutics Ltd. and Visus Therapeutics Inc. have officially merged, combining their respe...
read moreVSY Biotechnology GmbH, a global leader in ophthalmic innovation and research, has announced the app...
read moreVisiRose, a newly established company is advancing the development of Rose Bengal Photodynamic Antim...
read moreNona Biosciences has announced a strategic partnership with Kodiak Sciences Inc. to advance the deve...
read moreViaLase has announced a groundbreaking research partnership with the John A. Moran Eye Center at the...
read moreVivaVision Biotech has announced promising phase 2 clinical trial results for VVN461, a nonsteroidal...
read moreThe OneSight EssilorLuxottica Foundation has entered a strategic partnership with the World Health O...
read moreCambium Bio Limited, a clinical-stage regenerative medicine company, announced that it has successfu...
read moreGalimedix Therapeutics Inc. has announced the initiation of dosing in a Phase 1 clinical trial for o...
read more